Wall Street Zen lowered shares of Adient (NYSE:ADNT – Free Report) from a buy rating to a hold rating in a report released on Saturday morning.
Other equities analysts have also recently issued reports about the stock. Citigroup began coverage on shares of Adient in a research report on Wednesday, April 23rd. They issued a “neutral” rating and a $14.00 price objective for the company. Barclays cut shares of Adient from an “equal weight” rating to a “negative” rating in a research report on Tuesday, April 15th. Wells Fargo & Company upped their price objective on shares of Adient from $14.00 to $17.00 and gave the company an “equal weight” rating in a research report on Monday, May 19th. Bank of America cut shares of Adient from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $24.00 to $18.00 in a research report on Tuesday, March 4th. Finally, Morgan Stanley decreased their price objective on shares of Adient from $17.00 to $16.00 and set an “underweight” rating for the company in a research report on Monday, May 19th. Three investment analysts have rated the stock with a sell rating and eight have given a hold rating to the company’s stock. According to data from MarketBeat, Adient currently has an average rating of “Hold” and an average target price of $18.17.
View Our Latest Stock Report on ADNT
Adient Stock Up 3.9%
Adient (NYSE:ADNT – Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.33. Adient had a negative net margin of 0.01% and a positive return on equity of 6.94%. The firm had revenue of $3.61 billion during the quarter, compared to analysts’ expectations of $3.39 billion. During the same period in the prior year, the company earned $0.54 EPS. The firm’s revenue was down 3.7% on a year-over-year basis. Equities research analysts forecast that Adient will post 1.76 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Adient
Institutional investors and hedge funds have recently bought and sold shares of the business. JPMorgan Chase & Co. raised its stake in Adient by 96.5% during the fourth quarter. JPMorgan Chase & Co. now owns 802,540 shares of the company’s stock worth $13,828,000 after acquiring an additional 394,111 shares during the period. Northern Trust Corp raised its stake in Adient by 6.8% during the fourth quarter. Northern Trust Corp now owns 1,129,645 shares of the company’s stock worth $19,464,000 after acquiring an additional 72,077 shares during the period. Pzena Investment Management LLC raised its stake in Adient by 28.5% during the fourth quarter. Pzena Investment Management LLC now owns 3,629,452 shares of the company’s stock worth $62,535,000 after acquiring an additional 803,961 shares during the period. Quantbot Technologies LP raised its stake in Adient by 263.6% during the fourth quarter. Quantbot Technologies LP now owns 80,294 shares of the company’s stock worth $1,383,000 after acquiring an additional 58,209 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Adient by 105.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 369,035 shares of the company’s stock worth $6,358,000 after acquiring an additional 189,574 shares during the period. Institutional investors and hedge funds own 92.44% of the company’s stock.
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Further Reading
- Five stocks we like better than Adient
- High Flyers: 3 Natural Gas Stocks for March 2022
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- What Are Some of the Best Large-Cap Stocks to Buy?
- Palantir Defies Bears, Leads S&P 500 in 2025
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.